Omada Health, Inc. (OMDA)

Nasdaq: OMDA · Services-Health Services · South San Francisco, CA · filing with the SEC since 2014

Full chart Alerts Compare

Grade6.2

◀ Past 5.7● Present 6.1▶ Future 6.7

3 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The grade of Omada Health, Inc.

Nine metrics read from its own filings, by tense

Headline grade

6.2/10

◀ Past5.730% of the headline

● Present6.140% of the headline

▶ Future6.730% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 6 read as filed from the record and 3 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

5.7/1030% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed

8.3/10

Has it survived what it has been through?

No warning events in its filings since 2017.

weight 33% of this tense · 83rd percentile among 15 sector filers · read for itself

From the record

Omada Health, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed

6.3/10

What has it actually done, year after year?

+45.5% a year over 3 filed years; profitable in 0 of 3.

weight 45% of this tense · 63rd percentile among 14 sector filers · read for its customers

From the record

Omada Health, Inc.'s 3 filed years say what it did: revenue went from $123 million in fiscal 2023 to $260 million in fiscal 2025, up 45.5% a year; it rose in 2 of 2 years; it never fell from a peak; net income was positive in 0 of 3 of those years (its annual reports).

What it rests on

revenue growth over the filed span45.5%top 18% of its family
the share of years revenue rosetop 21% of its family
the share of filed years with a profitbottom 14% of its family
the deepest fall from a revenue peak0.0%top 21% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate

0.4/10

How has it treated the people who own it?

SI estimate 0.4/10, confidence 35 of 100 (one part).

weight 22% of this tense · 4th percentile among 14 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Read from one part only, the share count over the years, which ranks in the bottom 4% of 14 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read: Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned: one part: the share count over the years, the one part on file, ranked among 14 in its family.
Confidence: 35 of 100
What would change it: A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Omada Health, Inc.'s shareholder treatment is put at 0.4 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 4% of 14 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

6.1/1040% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed

4.8/10

Is it financially healthy right now?

ROE -6%: lost 6¢ per shareholder dollar. Leverage 25%: owes 25¢ per asset dollar.

weight 33% of this tense · 48th percentile among 14 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Omada Health, Inc. lost about 6 cents for every dollar of shareholders' money, and gross profitability: its products earned about 56 cents per dollar of everything the company owns. Leverage: it owed about 25 cents per dollar of assets, and net share issuance: its share count grew 374.5% over the year (the filed statements).

What it rests on

what it owes per dollar of assetstop 25% of its family
return on equitybottom 38% of its family
gross profit against assetstop 31% of its family
the share count against the year beforebottom 11% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed

5.8/10

How strong is its position in its industry?

top 42% of 14 in its family; net margin -4.9%.

weight 45% of this tense · 58th percentile among 14 sector filers · read for its customers

From the record

Omada Health, Inc.'s standing among 14 graded names in its industry family: revenue of $260 million in fiscal 2025 ranks in the bottom 39% by size; a net margin of -4.9% ranks in the bottom 46%; revenue growth of 45.5% a year over the last 2 filed years ranks in the top 11% (its annual reports).

What it rests on

revenue against the family$260Mbottom 39% of its family
net margin-4.9%bottom 46% of its family
three-year revenue growth45.5%top 11% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate

8.8/10

What are the people in charge doing?

SI estimate 8.8/10, confidence 35 of 100 (one part).

weight 22% of this tense · 88th percentile among 13 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the top 12% of 13 in its family; the record of its people begins on 2025-06-05 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 1.4 years and cannot see past it; a floor under five years is not read as years in charge.
What the record cannot read: The record of its people begins on 2025-06-05 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 1.4 years and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned: one part: officer and director changes on Form 8-K, against the people in charge, the one part on file, ranked among 13 in its family.
Confidence: 35 of 100
What would change it: A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Omada Health, Inc.'s leadership is put at 8.8 of 10 with a confidence of 35 of 100, because read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the top 12% of 13 in its family; the record of its people begins on 2025-06-05 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 1.4 years and cannot see past it; a floor under five years is not read as years in charge. A filing that carries the missing parts replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

6.7/1030% of the headline grade · 2 of 3 filed, 1 estimated

Room to expand

as filed

7.9/10

How much room does it have to grow?

top 21% of 14 in its family for room to expand.

weight 22% of this tense · 79th percentile among 14 sector filers · read for itself

From the record

Omada Health, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $222 million against debt of $0 thousand leaves 72.7% of its assets as net cash, top 4% of its family; cash from operations less capital spending is 6.5% of revenue (top 32%); a gross margin of 65.7% (top 19%); research spending of 15.6% of revenue (top 30%) (its annual report).

What it rests on

cash less debt against assets72.7%top 4% of its family
cash from operations less capital spending against revenue6.5%top 32% of its family
gross margin65.7%top 19% of its family
research spending against revenue15.6%top 30% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed

7.2/10

What could actually drive growth from here?

top 28% of 14 in its family for growth drivers.

weight 45% of this tense · 72nd percentile among 14 sector filers · read for its customers

From the record

Omada Health, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 45.5% a year over the last three filed years against 45.5% over all 3, speeding up (top 43% of its family); the newest year grew 53.3% (top 11%); research spending grew 9.8% a year (top 30%); capital spending grew 78.2% a year (top 27%) (its annual reports). Omada Health, Inc. reported 2 product lines in fiscal 2025: Service at $241 million (93%), Hardware at $19 million (7%); 2 of 2 grew against the year before (its annual report).

What it rests on

three-year growth against the whole span+0.0 points a yeartop 43% of its family
the newest year's revenue growth53.3%top 11% of its family
three-year growth of research spending9.8%top 30% of its family
three-year growth of capital spending78.2%top 27% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

SI estimate

5.3/10

Did its newest year beat what its own record pointed to?

SI estimate 5.3/10, confidence 20 of 100 (family median).

weight 33% of this tense · 50th percentile among 12 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 12 members with one.
What the record cannot read: The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change.
How it was reasoned: family median, 12 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Omada Health, Inc.'s expectations vs reality is put at 5.3 of 10 with a confidence of 20 of 100, because the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 12 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton OMDA · research, not advice